Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06633952 · ClinicalTrials.gov registry record · NA
Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain Stimulation
A NA study of Aging and MCI, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06633952 is a NA study of Aging and MCI that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 90 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06633952, a NA study of Aging and MCI, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to collect pilot feasibility and early efficacy data showing improvements in cognition and wellbeing in adults with mild cognitive impairment (MCI) through a combination treatment of non-invasive brain stimulation (transcranial alternating current stimulation (tACS)) and a one of two digital cognitive interventions.
Interventions
- DEVICE MediTrain
- DEVICE wrist worn multi-sensor watches
- DEVICE Worder
- DEVICE noninvasive neurostimulation device
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06633952
The ClinicalTrials.gov registry entry for NCT06633952 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 4 interventions - of which MediTrain is the first listed.
NCT06633952 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06633952 about?
NCT06633952 is a clinical study titled "Accelerating Cognitive Gains From Digital Inverventions With Noninvasive Brain Stimulation". The overall goal of this project is to collect pilot feasibility and early efficacy data showing improvements in cognition and wellbeing in adults with mild cognitive impairment (MCI) through a combination treatment of non-invasive brain stimulation (transcranial alternating current stimulation (tAC...
What is the current status of trial NCT06633952?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-09-13. Estimated completion is 2026-12.
What conditions does trial NCT06633952 study?
This clinical trial studies the following conditions: Aging, MCI.
What interventions are being tested in trial NCT06633952?
The interventions under investigation include: MediTrain (DEVICE), wrist worn multi-sensor watches (DEVICE), Worder (DEVICE), noninvasive neurostimulation device (DEVICE).
Who is sponsoring clinical trial NCT06633952?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06633952 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.